Going Full TILt: challenges, successes, and coordination with administering TIL therapy

We are excited to announce an upcoming Rx-cited: Clinical Conundrums roundtable on Wednesday, December 17 from 2-3 p.m. CST that will discuss challenges, key points, and future directions associated with offering Tumor Infiltrating Lymphocyte (TIL) therapy. This will be a great opportunity to explore and discuss latest advancements impacting HCT and cellular therapy and connect with your peers on these recent developments in our field. 

Expect a lively, informal Q&A session moderated by members of the ASTCT Pharmacy SIG Research Subcommittee and New Practitioner Task Force. Through chat or open dialogue, you’ll have the opportunity to share insights and learn from your peers in transplantation and cellular therapy.

This event is open to all ASTCT members and non-members working in transplantation and cellular therapy. Have a question you'd like to see covered during the session? Submit it here: https://forms.office.com/r/mmWmwHea9T